The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maus, U. A.
Right arrow Articles by Lohmeyer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maus, U. A.
Right arrow Articles by Lohmeyer, J.
The Journal of Immunology, 2004, 173: 1307-1312.
Copyright © 2004 by The American Association of Immunologists

Pneumolysin-Induced Lung Injury Is Independent of Leukocyte Trafficking into the Alveolar Space1

Ulrich A. Maus2,*, Mrigank Srivastava*, James C. Paton{dagger}, Matthias Mack{ddagger}, M. Brett Everhart§, Timothy S. Blackwell§, John W. Christman§, Detlef Schlöndorff{ddagger}, Werner Seeger* and Jürgen Lohmeyer*

* Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Justus-Liebig University, Giessen, Germany; {dagger} School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia; {ddagger} Medical Policlinic, University of Munich, Munich, Germany; and § Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, and Department of Veterans Affairs, Nashville, TN 37232

Pneumolysin (PLY) is a major virulence factor released by Streptococcus pneumoniae and has been implicated in the pathogenesis of pneumococcal pneumonia. In this study, we evaluated the contribution of newly recruited neutrophils and monocytes and resident alveolar macrophages to the pathogenesis of PLY-induced lung injury. Mice received either adhesion-blocking Abs to inhibit alveolar leukocyte trafficking or liposomal clodronate to deplete alveolar macrophages before intratracheal application of native PLY or its noncytotoxic derivative PdB. We found that treatment with PLY but not PdB resulted in increased lung vascular permeability. In addition, PLY also induced a decrease in the resident alveolar macrophage population, and the recruitment of peripheral blood neutrophils and monocytes into the alveolar space. Blockade of PLY-induced alveolar leukocyte trafficking by pretreatment of mice with anti-CD18 plus anti-CD49d Abs or depletion of circulating neutrophils did not attenuate the increase in lung permeability observed in response to intratracheal PLY. In addition, depletion of resident alveolar macrophages with clodronated liposomes did not reduce alveolar injury developing in response to PLY. PLY-induced lung injury was associated with only a small increase in bronchoalveolar lavage concentrations of cytokines. These data indicate that PLY-induced lung injury results from direct pneumotoxic effects on the alveolar-capillary barrier and is independent of both resident and recruited phagocytic cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. A. Matthias, A. M. Roche, A. J. Standish, M. Shchepetov, and J. N. Weiser
Neutrophil-Toxin Interactions Promote Antigen Delivery and Mucosal Clearance of Streptococcus pneumoniae
J. Immunol., May 1, 2008; 180(9): 6246 - 6254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Taut, C. Winter, D. E. Briles, J. C. Paton, J. W. Christman, R. Maus, R. Baumann, T. Welte, and U. A. Maus
Macrophage Turnover Kinetics in the Lungs of Mice Infected with Streptococcus pneumoniae
Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 105 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Winter, K. Taut, F. Langer, M. Mack, D. E. Briles, J. C. Paton, R. Maus, M. Srivastava, T. Welte, and U. A. Maus
FMS-Like Tyrosine Kinase 3 Ligand Aggravates the Lung Inflammatory Response to Streptococcus pneumoniae Infection in Mice: Role of Dendritic Cells
J. Immunol., September 1, 2007; 179(5): 3099 - 3108.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Winter, K. Taut, M. Srivastava, F. Langer, M. Mack, D. E. Briles, J. C. Paton, R. Maus, T. Welte, M. D. Gunn, et al.
Lung-Specific Overexpression of CC Chemokine Ligand (CCL) 2 Enhances the Host Defense to Streptococcus pneumoniae Infection in Mice: Role of the CCL2-CCR2 Axis
J. Immunol., May 1, 2007; 178(9): 5828 - 5838.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
U. A. Maus, M. Backi, C. Winter, M. Srivastava, M. K. Schwarz, T. Ruckle, J. C. Paton, D. Briles, M. Mack, T. Welte, et al.
Importance of Phosphoinositide 3-Kinase {gamma} in the Host Defense against Pneumococcal Infection
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Anderson, H. C. Steel, R. Cockeran, A. M. Smith, A. von Gottberg, L. de Gouveia, A. Brink, K. P. Klugman, T. J. Mitchell, and C. Feldman
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae
J. Antimicrob. Chemother., February 1, 2007; 59(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
U. A. Maus, S. Janzen, G. Wall, M. Srivastava, T. S. Blackwell, J. W. Christman, W. Seeger, T. Welte, and J. Lohmeyer
Resident Alveolar Macrophages Are Replaced by Recruited Monocytes in Response to Endotoxin-Induced Lung Inflammation
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L.-A. S. Kirkham, A. R. Kerr, G. R. Douce, G. K. Paterson, D. A. Dilts, D.-F. Liu, and T. J. Mitchell
Construction and Immunological Characterization of a Novel Nontoxic Protective Pneumolysin Mutant for Use in Future Pneumococcal Vaccines
Infect. Immun., January 1, 2006; 74(1): 586 - 593.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.